Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

World Medical CE-marks endoluminal stent grafts:

This article was originally published in Clinica

Executive Summary

World Medical has CE-marked its TALENT LPS family of endoluminal stent grafts which are designed to repair balloon-like swellings of the aorta in the abdominal, iliac and thoracic regions. These aneurysms result from the weakening of the artery walls, and if left untreated, continue to enlarge and finally rupture. The new generation of stent grafts, based on the company's original TALENT products, employs a precision woven graft material and a longer, more flexible tip on the delivery system. Results from clinical studies have shown that the graft material is more durable and smaller than conventional grafts, says World Medical.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel